NCT05023811View on ClinicalTrials.gov

A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
HealthyADME
Interventions
DRUG

[14C]RIST4271

\[14C\]RIST4271 oral solution

Trial Locations (1)

Unknown

Quotient Sciences Ltd, Nottingham

Sponsors
All Listed Sponsors
lead

Aristea Therapeutics, Inc.

INDUSTRY

NCT05023811 - A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter